 |
|
Combined Levothyroxine Plus Liothyronine Compared With Levothyroxine Alone in Primary Hypothyroidism
A Randomized Controlled Trial
Patrick W. Clyde, MD;
Amir E. Harari, MD;
Eric J. Getka, PhD;
K. M. Mohamed Shakir, MD
JAMA. 2003;290:2952-2958.
Context Standard therapy for patients with primary hypothyroidism is replacement with synthetic thyroxine, which undergoes peripheral conversion to triiodothyronine, the active form of thyroid hormone. Within the lay population and in some medical communities, there is a perception that adding synthetic triiodothyronine, or liothyronine, to levothyroxine improves the symptoms of hypothyroidism despite insufficient evidence to support this practice.
Objective To evaluate the benefits of treating primary hypothyroidism with levothyroxine plus liothyronine combination therapy vs levothyroxine monotherapy.
Design, Setting, and Patients Randomized, double-blind, placebo-controlled trial conducted from May 2000 to February 2002 at a military treatment facility that serves active duty and retired military personnel and their family members. The trial included a total of 46 patients aged 24 to 65 years with at least a 6-month history of treatment with levothyroxine for primary hypothyroidism.
Intervention Patients received either their usual dose of levothyroxine (n = 23) or combination therapy (n = 23), in which their usual levothyroxine dose was reduced by 50 µg/d and substituted with liothyronine, 7.5 µg, taken twice daily for 4 months.
Main Outcome Measures Scores on a hypothyroid-specific health-related quality-of-life (HRQL) questionnaire, body weight, serum lipid levels, and 13 neuropsychological tests measured before and after treatment.
Results Serum thyrotropin levels remained similar and within the normal range in both treatment groups from baseline to 4 months. Body weight and serum lipid levels did not change. The HRQL questionnaire scores improved significantly in both the control group (23%; P<.001) and the combination therapy group (12%; P = .02), but these changes were statistically similar (P = .54). In 12 of 13 neuropsychological tests, outcomes between groups were not significantly different; the 1 remaining test (Grooved Peg Board) showed better performance in the control group.
Conclusion Compared with levothyroxine alone, treatment of primary hypothyroidism with combination levothyroxine plus liothyronine demonstrated no beneficial changes in body weight, serum lipid levels, hypothyroid symptoms as measured by a HRQL questionnaire, and standard measures of cognitive performance.
Author Affiliations: Department of Endocrinology and Metabolism, Nation Naval Medical Center, Bethesda, Md (Drs Clyde and Shakir); Department of Endocrinology and Metabolism (Dr Harari) and Department of Psychology (Dr Getka), Naval Medical Center San Diego, San Diego, Calif.
RELATED LETTER
Synthetic Thyroxine vs Dessicated Thyroid
Edward M. Lichten
JAMA. 2004;291(12):1445.
EXTRACT
| FULL TEXT
RELATED ARTICLES
Combined T4 and T3 Therapy—Back to the Drawing Board
David S. Cooper
JAMA. 2003;290(22):3002-3004.
EXTRACT
| FULL TEXT
Hypothyroidism
Sharon Parmet, Cassio Lynm, and Richard M. Glass
JAMA. 2003;290(22):3024.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Triiodothyronine Levels in Athyreotic Individuals During Levothyroxine Therapy
Jonklaas et al.
JAMA 2008;299:769-777.
ABSTRACT
| FULL TEXT
Treatment of Clinical Hypothyroidism With Thyroxine and Triiodothyronine: A Literature Review and Metaanalysis
Joffe et al.
Psychosomatics 2007;48:379-384.
ABSTRACT
| FULL TEXT
Combined Treatment With Sertraline and Liothyronine in Major Depression: A Randomized, Double-blind, Placebo-Controlled Trial
Cooper-Kazaz et al.
Arch Gen Psychiatry 2007;64:679-688.
ABSTRACT
| FULL TEXT
Thyroxine-Triiodothyronine Combination Therapy Versus Thyroxine Monotherapy for Clinical Hypothyroidism: Meta-Analysis of Randomized Controlled Trials
Grozinsky-Glasberg et al.
J. Clin. Endocrinol. Metab. 2006;91:2592-2599.
ABSTRACT
| FULL TEXT
Polymorphisms in Type 2 Deiodinase Are Not Associated with Well-Being, Neurocognitive Functioning, and Preference for Combined Thyroxine/3,5,3'-Triiodothyronine Therapy
Appelhof et al.
J. Clin. Endocrinol. Metab. 2005;90:6296-6299.
ABSTRACT
| FULL TEXT
Treatment of Hypothyroidism with Combinations of Levothyroxine plus Liothyronine
Escobar-Morreale et al.
J. Clin. Endocrinol. Metab. 2005;90:4946-4954.
ABSTRACT
| FULL TEXT
Combined Therapy with Levothyroxine and Liothyronine in Two Ratios, Compared with Levothyroxine Monotherapy in Primary Hypothyroidism: a Double-Blind, Randomized, Controlled Clinical Trial
Appelhof et al.
J. Clin. Endocrinol. Metab. 2005;90:2666-2674.
ABSTRACT
| FULL TEXT
Thyroid Hormone Replacement Therapy in Primary Hypothyroidism: A Randomized Trial Comparing L-Thyroxine plus Liothyronine with L-Thyroxine Alone
Escobar-Morreale et al.
ANN INTERN MED 2005;142:412-424.
ABSTRACT
| FULL TEXT
Partial Substitution of Thyroxine (T4) with Tri-Iodothyronine in Patients on T4 Replacement Therapy: Results of a Large Community-Based Randomized Controlled Trial
Saravanan et al.
J. Clin. Endocrinol. Metab. 2005;90:805-812.
ABSTRACT
| FULL TEXT
Update in Endocrinology
Schlechte
ANN INTERN MED 2005;142:126-131.
FULL TEXT
Synthetic Thyroxine vs Dessicated Thyroid
Lichten
JAMA 2004;291:1445-1445.
FULL TEXT
Other articles noted
Evid. Based Med. 2004;9:63-64.
FULL TEXT
Combined T3/T4 for Hypothyroidism -- Again, No Better Than T4
JWatch Psychiatry 2004;2004:8-8.
FULL TEXT
Combined T3/T4 for Hypothyroidism -- Again, No Better Than T4
JWatch Gastroenterology 2004;2004:10-10.
FULL TEXT
Combined T3/T4 for Hypothyroidism -- Again, No Better Than T4
JWatch General 2003;2003:2-2.
FULL TEXT
Combined T4 and T3 Therapy--Back to the Drawing Board
Cooper
JAMA 2003;290:3002-3004.
FULL TEXT
|
